Cutaneous anaplastic large-cell lymphoma with dramatic response to brentuximab vedotin; [Brentuximab vedotine dramatik yanıtlı kutanöz anaplastik büyük hücreli lenfoma]

Simple item page
dc.contributor.authorŞahin M.
dc.contributor.authorMiskioğlu M.
dc.contributor.authorInanır I.
dc.contributor.authorAkar H.
dc.contributor.authorNeşe N.
dc.contributor.authorTemiz P.
dc.contributor.authorAydoğdu İ.
dc.date.accessioned2024-07-22T08:06:37Z
dc.date.available2024-07-22T08:06:37Z
dc.date.issued2021
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.4274/tjh.galenos.2020.2020.0512
dc.identifier.issn13007777
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13621
dc.language.isoEnglish
dc.publisherTurkish Society of Hematology
dc.rightsAll Open Access; Gold Open Access
dc.subjectAged, 80 and over
dc.subjectAntineoplastic Agents, Immunological
dc.subjectBrentuximab Vedotin
dc.subjectFemale
dc.subjectHumans
dc.subjectLymphoma, Large-Cell, Anaplastic
dc.subjectSkin
dc.subjectSkin Neoplasms
dc.subjectTreatment Outcome
dc.subjectanastrozole
dc.subjectbrentuximab vedotin
dc.subjectlactate dehydrogenase
dc.subjectbrentuximab vedotin
dc.subjectimmunological antineoplastic agent
dc.subjectaged
dc.subjectanaplastic large cell lymphoma
dc.subjectbone lesion
dc.subjectbone marrow biopsy
dc.subjectbreast carcinoma
dc.subjectbreast disease
dc.subjectbreast imaging reporting and data system
dc.subjectbreast nodule
dc.subjectbreast tumor
dc.subjectcancer regression
dc.subjectcase report
dc.subjectcell infiltration
dc.subjectclinical article
dc.subjectdaily life activity
dc.subjecterythema
dc.subjecterythematous plaque
dc.subjectface injury
dc.subjectfemale
dc.subjectfrailty
dc.subjecthemoglobin blood level
dc.subjecthistopathology
dc.subjecthuman
dc.subjectLetter
dc.subjectloss of appetite
dc.subjectmammography
dc.subjectmonotherapy
dc.subjectmultiple cycle treatment
dc.subjectpositron emission tomography-computed tomography
dc.subjectskin defect
dc.subjecttreatment response
dc.subjectulcer
dc.subjectvery elderly
dc.subjectweakness
dc.subjectanaplastic large cell lymphoma
dc.subjectpathology
dc.subjectskin
dc.subjectskin tumor
dc.subjecttreatment outcome
dc.titleCutaneous anaplastic large-cell lymphoma with dramatic response to brentuximab vedotin; [Brentuximab vedotine dramatik yanıtlı kutanöz anaplastik büyük hücreli lenfoma]
dc.typeLetter

Files

Collections

Scopus Koleksiyonu